Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for Iambic Therapeutics, Shein, and 370+ companies. 5-min read every Tuesday.
Iambic Therapeutics uses AI-assisted drug discovery combining molecular simulation, high-throughput virtual screening, and experimental validation to identify novel therapeutics for challenging diseases. Valued at $500M with $150M raised, Iambic has multiple discovery programs in oncology and rare diseases. Major AI biotech IPO candidate as AI-driven small molecule drug discovery accelerates through clinical validation and partnership deals with major pharma.
| Industry | Biotechnology |
| Stage | Series C |
| IPO Status | Private |
| Valuation | $1.2B |
| Total Funding | $263M |
| Headquarters | San Diego, CA |
Shein is the world's largest fast fashion company, valued at $66B with $5.2B raised. Track IPO readiness score, funding history, and public market timeline.
| Industry | E-Commerce |
| Stage | Pre-IPO |
| IPO Status | Pre-IPO |
| Valuation | $30-50B |
| Total Funding | $5.2B |
| Headquarters | Singapore |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
Iambic Therapeutics is valued at $1.2B. Shein is valued at $30-50B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
Iambic Therapeutics is currently private. Shein filed an S-1 in June 2024 and is actively in the IPO pipeline. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
Iambic Therapeutics has raised $263M. Shein has raised $5.2B.
Iambic Therapeutics operates in Biotechnology, while Shein operates in E-Commerce.
Iambic Therapeutics is a Biotechnology company valued at $1.2B with $263M raised. Shein is a E-Commerce company valued at $30-50B with $5.2B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in Iambic Therapeutics and Shein through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.